Measurement of kidney perfusion by magnetic resonance imaging: Comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1126-1133

  Ritt, Martin ^a   Janka, Rolf ^a   Schneider, Markus P ^a   Martirosian, Petros ^b   Hornegger, Joachim ^a   Bautz, Werner ^a   Uder, Michael ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Kidney perfusion; Magnetic resonance imaging; Para aminohippuric acid plasma clearance; Renal plasma flow

Indexed keywords

AMLODIPINE; ATENOLOL; CREATININE; HYDROCHLOROTHIAZIDE; METOPROLOL; TELMISARTAN;

4 AMINOHIPPURIC ACID CLEARANCE; ARTICLE; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; KIDNEY PLASMA FLOW; KIDNEY SLICE; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPIN LABELING; STEADY STATE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ARTERIES; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; CREATININE; HEMODYNAMICS; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; P-AMINOHIPPURIC ACID; RENAL CIRCULATION; RENAL PLASMA FLOW; SPIN LABELS; YOUNG ADULT;

EID: 77950190399     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp639     Document Type: Article

References (31)

1. Bertolotto M, Quaia E, Galli G, et al. Color Doppler sonographic appearance of renal perforating vessels in subjects with normal and impaired renal function. J Clin Ultrasound 2000; 28: 267-276
2. Petersen LJ, Petersen JR, Ladefoged SD, et al. The pulsatility index and the resistive index in renal arteries in patients with hypertension and chronic renal failure. Nephrol Dial Transplant 1995; 10: 2060-2064
3. Grenier N, Hauger O, Cimpean A, et al. Update of renal imaging. Semin Nucl Med 2006; 36: 3-15
4. Russell CD, Taylor AT, Dubovsky EV. Measurement of renal function with technetium-99m-MAG3 in children and adults. J Nucl Med 1996; 37: 588-593
5. Haufe SE, Riedmuller K, Haberkorn U. Nuclear medicine procedures for the diagnosis of acute and chronic renal failure. Nephron Clin Pract 2006; 103: c77-c84
6. Calamante F, Thomas DL, Pell GS, et al. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 1999; 19: 701-735
7. Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001; 13: 496-520
8. Martirosian P, Klose U, Mader I, et al. FAIR true-FISP perfusion imaging of the kidneys. Magn Reson Med 2004; 51: 353-361
9. Fenchel M, Martirosian P, Langanke J, et al. Perfusion MR imaging with FAIR true FISP spin labeling in patients with and without renal artery stenosis: initial experience. Radiology 2006; 238: 1013-1021
10. Schmieder RE, Delles C, Mimran A, et al. Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes. Diabetes Care 2007; 30: 1351-1356
11. Cole RB, Giangiacomo J, Ingelfinger JR, et al. Measurement of renal function without urine collection: a critical evaluation of the constant-infusion technique for determination of inulin and para-aminohippu- rate. N Engl J Med 1972; 287: 1109-1114
12. Ritt M, Ott C, Delles C, et al. Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes. Pharmacogenet Genomics 2008; 18: 699-707
13. Schmieder RE, Gatzka C, Schobel H, et al. Renal hemodynamic response to stress is influenced by ACE-inhibitors. Clin Nephrol 1994; 42: 381-388
14. Smith HW, Finkelstein N, Aliminosa L, et al. The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945; 24: 388-404
15. Rosenbaum JR, Kramer MS, Raja RM, et al. Determination of inulin and p-aminohippurate clearance without urine collection. Nephron 1973; 10: 347-359
16. Delles C, Schneider MP, Oehmer S, et al. Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes. Nephrol Dial Transplant 2004; 19: 2513-2518
17. Ritt M, Ott C, Raff U, et al. Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus. Am J Kidney Dis 2009; 53: 281-289
18. Karger N, Biederer J, Lusse S, et al. Quantitation of renal perfusion using arterial spin labeling with FAIR-UFLARE. Magn Reson Imaging 2000; 18: 641-647
19. Michaely HJ, Schoenberg SO, Ittrich C, et al. Renal disease: value of functional magnetic resonance imaging with flow and perfusion measurements. Invest Radiol 2004; 39: 698-705
20. Bubeck B, Brandau W, Weber E, et al. Pharmacogenetics of techne-tium-99m-MAG3 in humans. J Nucl Med 1990; 31: 1285-1298
21. Schäufele TG, Schlaich MP, Delles C, et al. Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress. Kidney Int 2006; 70: 1177-1181
22. Hellerstein S, Berenborn M, Alon U, et al. The renal clearance and infusion clearance of inulin are similar but not identical. Kidney Int 1993; 44: 1058-1061
23. Bergstran J, Bucht H, Ek J, et al. The renal excretion of para-amino-hippurate in normal persons and in patients with diseased kidneys. Scand J Clin Lab Invest 1959; 11: 361-369
24. van Hoft IMS, Groebbe D, Derkx FHM, et al. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991; 324: 1305-1309
25. Schmieder RE, Beil AH, Weihprecht H, et al. How should renal he-modynamic data be indexed in obesity? J Am Soc Nephrol 1995; 5: 1709-1713
26. Dukacz SA, Adams MA, Kline RL. Short-and long-term enalapril affect renal medullary hemodynamics in the spontaneously hypertensive rat. Am J Physiol 1999; 276: R10-R16
27. Ajayi AAL, Hercule HC, Pamugo J, et al. Interactions of the renin-angiotensin system and alpha-1 adrenoceptors on renal hemodynam-ics in healthy and acute renal failure rats: the role of nitric oxide. Blood Press 2001; 10: 238-246
28. Fliser D, Wagner K, Loos A, et al. Chronic angiotensin II receptor blockade reduces (intra)renal vascular resistance in patients with type 2 diabetes. J Am Soc Nephrol 2005; 16: 1135-1140
29. Wenting GJ, Tan-Tjiong HL, Derkx FH, et al. Splint renal function after captopril in unilateral renal artery stenosis. Br Med J (Clin Res Ed) 1984; 288: 886-890
30. Muller-Suur R, Tidgren B, Fehrm A, et al. Captopril-induced changes in MAG3 clearance in patients with renal arterial stenosis and the effect of renal angioplasty. J Nucl Med 2000; 41: 1203-1208
31. Jonker GJ, Visscher CA, de Zeeuw D, et al. Changes in renal function induced by ACE-inhibition in the conscious two-kidney, one-clip Goldblatt hypertensive dog. Nephron 1992; 60: 226-231